hydroxychloroquine has been researched along with Eye Abnormalities in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Eye Abnormalities: Congenital absence of or defects in structures of the eye; may also be hereditary.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kim, DA | 1 |
Rho, S | 1 |
Mulholland, CP | 1 |
Pollock, TJ | 1 |
2 other studies available for hydroxychloroquine and Eye Abnormalities
Article | Year |
---|---|
Peters Anomaly in One Premature Twin Following Hydroxychloroquine Exposure During Pregnancy: A Case Report.
Topics: Anterior Eye Segment; Corneal Opacity; Eye Abnormalities; Female; Humans; Hydroxychloroquine; Pregna | 2023 |
The Peters anomaly following antenatal exposure to methotrexate and hydroxychloroquine.
Topics: Anterior Eye Segment; Antirheumatic Agents; Arthritis, Rheumatoid; Corneal Opacity; Enzyme Inhibitor | 2011 |